109 Impact of ipilimumab/nivolumab on mesothelioma treatment and outcomes for the very elderly (80+ years): results from a large tertiary centre
Fields of Study & Subjects
Occupational and environmental lung diseases
Intraperitoneal and Appendiceal Malignancies
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Lung Cancer
- Volume
- 212
- Pages
- 109058–109058
- Publication date
- 1 February 2026
- Language
- EN